Skip to main content

Mulay James's Form 4 filing

CG Oncology, Inc. (CGON) · filed Jan 13, 2026

Accession no.
0001193125-26-011756
Filed
Jan 13, 2026
Trade date
Jan 9, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $584.8K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mulay JamesCIK 0001684531Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 9, 2026Common StockMOption exerciseAcquired+654$3.72+$2,432.88654Direct
Jan 9, 2026Common StockSSaleDisposed−654$44.16−$28,880.640Direct
Jan 9, 2026Common StockMOption exerciseAcquired+10,491$12.59+$132,081.6910,491Direct
Jan 9, 2026Common StockSSaleDisposed−10,491$52.99−$555,918.090Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 9, 2026Common StockMOption exerciseDisposed−654$0.00$01,308Direct
Jan 9, 2026Common StockMOption exerciseDisposed−10,491$0.00$05,240Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)